- Home
- APWC vs FBRX Comparison
APWC vs FBRX Comparison
Compare APWC & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- FBRX
- Stock Information
- Founded
- APWC 1996
- FBRX N/A
- Country
- APWC Taiwan
- FBRX United States
- Employees
- APWC N/A
- FBRX N/A
- Industry
- APWC Telecommunications Equipment
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- APWC Industrials
- FBRX Health Care
- Exchange
- APWC Nasdaq
- FBRX Nasdaq
- Market Cap
- APWC 30.1M
- FBRX 35.3M
- IPO Year
- APWC 1997
- FBRX N/A
- Fundamental
- Price
- APWC $1.52
- FBRX $7.35
- Analyst Decision
- APWC
- FBRX Strong Buy
- Analyst Count
- APWC 0
- FBRX 4
- Target Price
- APWC N/A
- FBRX $76.58
- AVG Volume (30 Days)
- APWC 4.1K
- FBRX 54.6K
- Earning Date
- APWC 03-31-2025
- FBRX 05-12-2025
- Dividend Yield
- APWC N/A
- FBRX N/A
- EPS Growth
- APWC N/A
- FBRX N/A
- EPS
- APWC 0.17
- FBRX N/A
- Revenue
- APWC $472,672,000.00
- FBRX N/A
- Revenue This Year
- APWC N/A
- FBRX N/A
- Revenue Next Year
- APWC N/A
- FBRX N/A
- P/E Ratio
- APWC $8.82
- FBRX N/A
- Revenue Growth
- APWC 11.02
- FBRX N/A
- 52 Week Low
- APWC $1.24
- FBRX $4.11
- 52 Week High
- APWC $2.02
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- APWC 47.48
- FBRX 44.84
- Support Level
- APWC $1.47
- FBRX $7.10
- Resistance Level
- APWC $1.59
- FBRX $9.04
- Average True Range (ATR)
- APWC 0.04
- FBRX 1.32
- MACD
- APWC -0.00
- FBRX 0.34
- Stochastic Oscillator
- APWC 34.71
- FBRX 50.62
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).